Intuitive Surgical (NASDAQ: ISRG) shares surged 13.22% to $444.00 in pre-market trading after the company reported better-than-expected Q2 earnings. Analysts at Raymond James upgraded Intuitive Surgical from Market Perform to Outperform.
Eagle Pharmaceuticals (NASDAQ: EGRX) shares jumped 8.65% to $14.20 in pre-market trading after the company announced the FDA approval for malignant hyperthermia with Ryanodex.
JAKKS Pacific (NASDAQ: JAKK) shares gained 7.31% to $8.95 in pre-market trading after the company reported a Q2 loss of $0.43 per share on revenue of $124.20 million.
Biogen Idec (NASDAQ: BIIB) shares gained 6.69% to $324.00 in pre-market trading after the company reported upbeat Q2 results and lifted its FY14 forecast.
Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Most Popular Analysts Comment On Apple Before Q3 Earnings UPDATE: UBS Raises Price Target On Apple Earnings Scheduled For July 22, 2014 Morgan Stanley Needs Better Entry Point For General Electric Microsoft Cloud Results, Nokia Key To Fiscal Q4 And Outlook Microsoft Misses FQ4 Bottom Line On 17% Revenue Growth Related Articles (BIIB + EGRX) Benzinga's Top #PreMarket Gainers US Stock Futures Rise Ahead Of Earnings FDA Approves Eagle Pharmaceuticals' Ryanodex For The Treatment Of Malignant Hyperthermia Earnings Scheduled For July 23, 2014 Biotech Enters Reporting Season With Large Caps Central To Sector Performance Ligand Pharmaceuticals (LGND) in Focus: Stock Falls 6.7% - Tale of the Tape
No comments:
Post a Comment